High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2). (Q33879249)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2). |
scientific article |
Statements
1 reference
High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2). (English)
1 reference
Gilles Montalescot
1 reference
Farzin Beygui
1 reference
Guillaume Cayla
1 reference
Jean-Philippe Collet
1 reference
Jean-Sébastien Hulot
1 reference
Ghalia Anzaha
1 reference
Ana Pena
1 reference
Thomas Chastre
1 reference
Claire Caron
1 reference
Johanne Silvain
1 reference
Anne Bellemain-Appaix
1 reference
Jean-Baptiste Vignalou
1 reference
Sophie Galier
1 reference
Olivier Barthélémy
1 reference
Vanessa Gallois
1 reference
CLOVIS-2 Investigators
1 reference
1 reference
Identifiers
1 reference